Photo of Steve McBradyPhoto of Jim Flood

Rebuilding America’s aging and technologically challenged infrastructure is increasingly seen as an imperative. The need to invest in and mobilize resources for critical infrastructure projects has become an ever greater priority given the role project development can play in lifting the U.S. economy in dire times.

Congress and the Administration are actively exploring various forms of infrastructure-related stimulus and associated legislation. We are closely monitoring, and are in regular contact with key officials who are driving the efforts. We are also working with companies focused on impacting the contours of such funding avenues and enabling legislation. Drawing upon our market-leading status in government contracting, we are also assisting clients to position themselves to be on the front end of the coming wave of infrastructure projects.

There are many moving pieces looming in the infrastructure space, with crucial questions to be answered. Among them:

  • What infrastructure line items are likely to appear in forthcoming legislation?
  • Who will be the major players in driving legislation development, negotiations, and enactment?
  • Which industry sectors stand most to gain, or lose, depending on the outcomes?
  • How will the specifics of COVID-19 experience drive project development and the formulation of new law?
  • What does infrastructure even mean in our digital age?
  • How can and will defense sectors, and government contracting agencies, participate?
  • What regulatory, court, and arbitral litigation will fall out of these legislative and development efforts, and how will savvy businesses prepare?

With all this swirling, we are pleased to offer a webinar series focused on both the immediate opportunities associated with government stimulus and the broader set of strategic issues for companies focused on not being left behind in the coming wave of infrastructure projects in this rapidly evolving landscape.

The first program in the series will be a workshop-style brainstorming session, to make sure a broad set of perspectives is explored.

Click here to register for the first webinar in the series, “Infrastructure Stimulus Panel: How to prepare for, and influence, the extent, scope and funding of US infrastructure projects,” on September 10, 2020.

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Steve McBrady Steve McBrady

Steve McBrady is a partner and co-chair of Crowell & Moring’s Government Contracts Group. He also serves as a member of the firm’s Finance and Strategic Growth Committees, where he has played a leading role in expanding client service offerings throughout the U.S.…

Steve McBrady is a partner and co-chair of Crowell & Moring’s Government Contracts Group. He also serves as a member of the firm’s Finance and Strategic Growth Committees, where he has played a leading role in expanding client service offerings throughout the U.S., Europe, Asia, and the Middle East.

In recent years, Steve has received the National Law Journal’s “Winning Litigator” award as a lawyer who has “tackled some of the most widely watched cases of the year,” as well as the “D.C. Trailblazer” award, recognizing lawyers who have “made significant marks on the practice.” In 2018, he was named “Government Contracts MVP” by Law360.

Photo of Jim Flood Jim Flood

Jim Flood is a partner in Crowell & Moring’s Washington, D.C. office and assists health care, energy, and financial services clients with legal, legislative, and regulatory issues. He is also chair of the firm’s Government Affairs Group.

A former federal prosecutor and counsel…

Jim Flood is a partner in Crowell & Moring’s Washington, D.C. office and assists health care, energy, and financial services clients with legal, legislative, and regulatory issues. He is also chair of the firm’s Government Affairs Group.

A former federal prosecutor and counsel to Senator Charles E. Schumer (D-NY), Jim has more than 20 years of experience assisting clients facing issues before the White House, Congress, the U.S. Department of Health and Human Services (HHS), the Centers for Medicare & Medicaid Services (CMS), the U.S. Department of Justice (DOJ), the U.S. Drug Enforcement Administration (DEA), the U.S. Food and Drug Administration (FDA), and other federal agencies. He also works with the firm’s Healthcare Group and healthcare fraud practice team to counsel clients on issues related to Medicare, Medicaid, Part D, long-term care, health care fraud, the False Claims Act (FCA), and the anti-kickback statute.

In the area of antitrust, he has advised and guided companies through public policy issues affecting mergers in the healthcare and technology sectors. In the energy sector, Jim has experience navigating renewable energy regulatory and policy matters, and he served as the General Counsel for the American Wind Energy Association (AWEA), the American Clean Skies Foundation (ACSF), and the Advanced Biofuels Association (ABFA).

In 2023, Jim was again named a “Top Lobbyist” by The Hill.

Prior to joining Crowell & Moring, Jim led all federal and state government relations for a Fortune 400 health care company with $6 billion annual revenue. Jim led the Government Affairs Department and oversaw the company’s advocacy before Congress, HHS, CMS, DEA, key trade groups, and engaged with the White House on regulatory issues. Previously, he assisted clients at Brownstein Hyatt Farber Schreck LLP, where he provided strategic government relations advice and counsel to Fortune 500 companies in the health care, financial services, and energy sectors. Prior to that, he served as an Assistant U.S. Attorney at DOJ, where he led federal and local criminal investigations of U.S. corporations and individuals, prosecuted federal white collar grand jury criminal investigations into health care fraud, securities fraud, mortgage fraud, and government contracts fraud. He tried approximately 80 federal or local jury or bench trials during his time at DOJ, and also led a two-year nationwide FCA investigation into the sale of defective bulletproof vests to federal law enforcement agencies.